Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Revenue $ 454 $ 370
Operating expenses:    
Research and development 12,562 11,116
General and administrative 4,865 4,075
Total operating expenses 17,427 15,191
Loss from operations (16,973) (14,821)
Other income, net 512 358
Net loss $ (16,461) $ (14,463)
Net loss per share applicable to common stockholders - basic and diluted $ (0.49) $ (0.48)
Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted 33,766,333 30,335,164